Lynn Ratner, M.D. — New York, New York

Lynn Ratner, M.D. is a clinical research site located in New York, New York, United States 10028.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Lynn Ratner, M.D. has participated in 1 clinical trials.

Therapeutic areas: Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lynn Ratner, M.D.?

Lynn Ratner, M.D. has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lynn Ratner, M.D. conducted?

Lynn Ratner, M.D. has 1 clinical trials on record. Their work covers Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor.

Is Lynn Ratner, M.D. accredited by Crixeo Health?

Lynn Ratner, M.D. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lynn Ratner, M.D.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.